Republic of Moldova vs Western Sahara: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Republic of Moldova
0.3%
in 2024
Western Sahara
0.3%
in 2024
Republic of Moldova rank
85th
Western Sahara rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Republic of Moldova
- Western Sahara
How they compare
Republic of Moldova currently reports 0.3% against 0.3% in Western Sahara, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Republic of Moldova ahead.
Republic of Moldova ranks 85th and Western Sahara ranks 85th of 246 countries.
Republic of Moldova has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Republic of Moldova | Western Sahara | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.2% | 0.2% | Republic of Moldova |
| 2020s | 0.3% | 0.2% | 0.1% | Republic of Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Republic of Moldova or Western Sahara?
- Republic of Moldova, at 0.3% against 0.3% in Western Sahara as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Republic of Moldova and Western Sahara?
- 0.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Western Sahara?
- 10 years are reported by both, from 2015 to 2024.
- How do Republic of Moldova and Western Sahara rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Republic of Moldova ranks 85th and Western Sahara ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.